Skip to main content
Not sure where to start? Get matched →
All answers

Cognitive · Reference

Best Place to Get PE-22-28 Online: How to Choose a Provider

The step-by-step ordering process is on the PE-22-28 how-to-get page, and the legal status is in do you need a prescription for PE-22-28. This page is about how to judge a provider.

PE-22-28 (Injectable)
PE-22-28$219/mo

The best place to get PE-22-28 online is a provider where a physician licensed in your state reviews an intake that asks about antidepressants and other serotonergic medications, mood history, diabetes and seizures, a named, licensed US 503A pharmacy compounds the vial in your name, lot test results are published, and the price includes everything. It should also say plainly that PE-22-28 has no published human trials of any kind. At Pepti, PE-22-28 is $219 a month all-in for a 5 mL vial holding 10 mg at 2 mg/mL, covering medication, physician review, refill management and refrigerated shipping. Compounded PE-22-28 is not FDA approved.

The step-by-step ordering process is on the PE-22-28 how-to-get page, and the legal status is in do you need a prescription for PE-22-28. This page is about how to judge a provider.

Best Place to Get PE-22-28 Online

The short answer

Criterion What good looks like Pepti
Licensed physician Licensed in your state; reads your intake; sometimes says no Yes; usually within 24 hours; a declined consultation is refunded
PE-22-28-specific screening Asks about serotonergic drugs, mood disorders, diabetes and seizure history Raised at intake
Named 503A pharmacy You can identify it and check its license PCAB-accredited, FDA-registered US 503A pharmacies, named on your label
Lot testing Lab, lot, method, sterility and endotoxin Published at lab results
All-in price One monthly figure $219 a month, no membership fee
Honest evidence claims Says the evidence is cell and rodent work only Stated plainly
Sport disclosure Tells athletes about WADA's S0 catch-all Stated plainly

Best Place to Get PE-22-28 Online

Why PE-22-28 needs a careful provider

PE-22-28 is a seven-amino-acid fragment of the sortilin propeptide, studied as a blocker of the TREK-1 potassium channel in nerve cells. The research behind it is real and interesting: a 2006 Nature Neuroscience paper found mice without TREK-1 behaved as though given an antidepressant, a 2010 PLoS Biology paper described spadin's antidepressant-like effects in mice, and a 2017 Frontiers in Pharmacology paper described PE-22-28 as the shortest fragment that kept the effect. None of it is in humans. With no human dose-finding, safety or efficacy data, the physician review and the honesty of the provider are doing most of the work.

The questions a real intake asks

Question Why it matters for PE-22-28
Do you take an antidepressant, a triptan, lithium, tramadol or any other serotonergic drug? The proposed mechanism runs through serotonin signalling, and the combination has not been studied in humans
Do you have a diagnosed mood disorder, and who manages it? PE-22-28 is not a treatment for depression; the physician managing a diagnosis needs to be part of the decision
Have you had thoughts of harming yourself? That is an emergency no peptide addresses
Do you have diabetes or take glucose-lowering medication? Cell work described the parent peptide increasing insulin secretion from pancreatic beta cells
Any seizure history? TREK-1 is involved in seizure protection; the rodent work found no problem, but it should be discussed
Are you pregnant or breastfeeding? Not used; safety data is absent
Are you a tested athlete? WADA's S0 section can apply to a substance with no human therapeutic approval

A process that approves in seconds has asked none of these. Bloodwork is not required for any Pepti treatment. If your physician wants labs for your care, they'll ask through your account.

A provider that tells you what the evidence is

The honest description of PE-22-28 is a research peptide with a plausible mechanism and a rodent literature, prescribed under supervision on the basis of that mechanism and clinical judgement. A provider who describes it that way, and who will point you towards compounds with a human record when that fits you better, is one worth trusting. A provider who describes it as a proven antidepressant or a nootropic with human data is overselling it.

Best Place to Get PE-22-28 Online

Claims that should make you leave

Claim What the record shows
"Natural antidepressant" No human trials of any kind; it is not an antidepressant in the regulatory sense
"Works in four days" The four-day result is from mice, not people
"Replace your SSRI" No existing antidepressant should be stopped on the strength of a rodent literature
"Boosts focus and memory" No human cognitive-performance data exists
"Clinically studied" The studies are cell and rodent work
"FDA approved" False; it is not approved for anything and compounded medications are not FDA approved
"No side effects" Human side effects are unknown because no trials have been run
"No prescription needed" A research-chemical seller

Best Place to Get PE-22-28 Online

Checking the pharmacy and the vial

Ask which pharmacy compounds the prescription and check its license with the state board of pharmacy. A 503A pharmacy compounds for an identified individual patient, so the label should carry your name, the drug, the strength, your directions, the pharmacy and a beyond-use date. The certificate of analysis should show the laboratory, lot, method and date, with sterility and bacterial endotoxin results for an injectable. How to read a certificate of analysis explains each line, and how to tell if a peptide seller is legitimate has the general checklist.

Compounded prescription Research-use-only vial
Screening for serotonergic drugs and mood history Yes No
Label Your name and directions "Not for human consumption"
Sterility and endotoxin Required No requirement
Shipping Refrigerated with ice packs Varies
After it arrives Message your care team Nobody to ask

Best Place to Get PE-22-28 Online

What Pepti's PE-22-28 prescription includes

Item Detail
Product PE-22-28 (Injectable)
Vial 5 mL multi-dose vial, 10 mg at 2 mg/mL, ready to use
Typical printed directions Inject 0.25 mL (25 units) subcutaneously once daily Monday through Friday
Amount per typical dose 0.5 mg (math only)
Doses per vial 20, about four weeks
Supplies Sterile syringes and alcohol prep pads
Shipping Refrigerated, insulated, with ice packs
Refills Every 28 days, one vial per fill, until you cancel
Price $219 a month all-in, no membership fee, cash-pay
Format Vial and syringe only
Availability Every state except Oklahoma, plus DC

Your physician sets your directions after reviewing your intake, and they are printed on the vial. The weekday schedule is a prescriber's schedule, not a trial-derived one; the rodent studies used short daily courses. Keep the vial refrigerated, upright and unfrozen, and do not use it past the beyond-use date on the label. See how to store peptides.

When a related peptide may be the better conversation

If your priority is A physician may discuss
A compound with a longer record of human use for mood and focus Selank or Semax, or the Semax + Selank preparation
Anxiety more than low mood Selank, or the SERENITY blend pairing it with DSIP
Sleep DSIP
Focus and cognition rather than mood Semax, the SYNAPSE blend or Dihexa
A diagnosed mood disorder Approved treatment, decided with whoever manages the diagnosis

Background is in what is PE-22-28 and peptides for anxiety and mood.

References

What this is based on.

References

  1. Djillani A, Pietri M, Moreno S et al.. Shortened Spadin Analogs Display Better TREK-1 Inhibition, In Vivo Stability and Antidepressant Activity · Front Pharmacol (2017) · PMID 28955242
  2. Mazella J, Pétrault O, Lucas G et al.. Spadin, a sortilin-derived peptide, targeting rodent TREK-1 channels: a new concept in the antidepressant drug design · PLoS Biol (2010) · PMID 20405001
  3. Heurteaux C, Lucas G, Guy N et al.. Deletion of the background potassium channel TREK-1 results in a depression-resistant phenotype · Nat Neurosci (2006) · PMID 16906152
  4. Moha Ou Maati H, Veyssiere J, Labbal F et al.. Spadin as a new antidepressant: absence of TREK-1-related side effects · Neuropharmacology (2012) · PMID 21807005
  5. Devader C, Khayachi A, Veyssière J et al.. In vitro and in vivo regulation of synaptogenesis by the novel antidepressant spadin · Br J Pharmacol (2015) · PMID 25598009
  6. Moha ou Maati H, Bourcier-Lucas C, Veyssiere J et al.. The peptidic antidepressant spadin interacts with prefrontal 5-HT(4) and mGluR(2) receptors in the control of serotonergic function · Brain Struct Funct (2016) · PMID 25233810
  7. Ye D, Li Y, Zhang X et al.. TREK1 channel blockade induces an antidepressant-like response synergizing with 5-HT1A receptor signaling · Eur Neuropsychopharmacol (2015) · PMID 26441141
  8. Hivelin C, Béraud-Dufour S, Devader C et al.. Potentiation of Calcium Influx and Insulin Secretion in Pancreatic Beta Cell by the Specific TREK-1 Blocker Spadin · J Diabetes Res (2016) · PMID 28105440
  9. Devader C, Roulot M, Moréno S et al.. Serum sortilin-derived propeptides concentrations are decreased in major depressive disorder patients · J Affect Disord (2017) · PMID 27838145
  10. Roulot M, Minelli A, Bortolomasi M et al.. Increased serum levels of sortilin-derived propeptide after electroconvulsive therapy in treatment-resistant depressed patients · Neuropsychiatr Dis Treat (2018) · PMID 30233189
  11. Qi X, Xu H, Wang L et al.. Comparison of Therapeutic Effects of TREK1 Blockers and Fluoxetine on Chronic Unpredicted Mild Stress Sensitive Rats · ACS Chem Neurosci (2018) · PMID 29952548
  12. Djillani A, Pietri M, Mazella J et al.. Fighting against depression with TREK-1 blockers: Past and future. A focus on spadin · Pharmacol Ther (2019) · PMID 30291907

Citations are provided for educational purposes. They do not constitute medical advice. Always discuss any peptide protocol with your prescribing physician.

Common questions

Best Place to Get PE-22-28 Online, answered.

A provider with a physician licensed in your state, an intake that screens serotonergic medications, mood history, diabetes and seizures, a named licensed 503A pharmacy, published lot testing, one all-in price and honest claims about the lack of human trials. Pepti offers PE-22-28 at $219 a month all-in through the free assessment.

Next step

See what a physician recommends for you.

A licensed physician in your state reviews your intake and decides what is appropriate. A consultation does not guarantee a prescription.